NCT04083781: A trial that was reported late by Novo Nordisk A/S
This trial has reported, although it was 18 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04083781 |
|---|---|
| Title | Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B With Inhibitors |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 21, 2019 |
| Completion date | Dec. 27, 2021 |
| Required reporting date | Dec. 27, 2024, midnight |
| Actual reporting date | Jan. 14, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 18 |